메뉴 건너뛰기




Volumn 32, Issue 9, 2010, Pages 1163-1173

Barriers to accessing care in patients with chronic hepatitis C: The impact of depression

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; EMPLOYMENT STATUS; EVALUATION; FEMALE; HEALTH CARE ACCESS; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL RECORD REVIEW; PERCEPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYMPTOM;

EID: 78649480282     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04460.x     Document Type: Article
Times cited : (40)

References (46)
  • 1
    • 0033584440 scopus 로고    scopus 로고
    • The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
    • Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1994; 341: 556-62.
    • N Engl J Med , vol.1994 , Issue.341 , pp. 556-562
    • Alter, M.J.1    Kruszon-Moran, D.2    Nainan, O.V.3
  • 3
    • 0033998786 scopus 로고    scopus 로고
    • The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
    • Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 31: 777-82.
    • (2000) Hepatology , vol.31 , pp. 777-782
    • Armstrong, G.L.1    Alter, M.J.2    McQuillan, G.M.3    Margolis, H.S.4
  • 4
    • 0036828840 scopus 로고    scopus 로고
    • National institutes of health consensus conference: Management of hepatitis C
    • Seeff L, Hoofnagle JH. National institutes of health consensus conference: management of hepatitis C. Hepatology 2002; 36: S1-20.
    • (2002) Hepatology , vol.36
    • Seeff, L.1    Hoofnagle, J.H.2
  • 5
    • 65449152185 scopus 로고    scopus 로고
    • Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection
    • McHutchison JG, Everson GT, Gordon SC, et al. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N Engl J Med 2009; 360: 1827-38.
    • (2009) N Engl J Med , vol.360 , pp. 1827-1838
    • McHutchison, J.G.1    Everson, G.T.2    Gordon, S.C.3
  • 6
    • 77950817619 scopus 로고    scopus 로고
    • Telaprevir for previously treated chronic HCV infection
    • McHutchison JG, Manns MP, Muir AJ, et al. Telaprevir for previously treated chronic HCV infection. N Engl J Med 2010; 362: 1292-303.
    • N Engl J Med , vol.2010 , Issue.362 , pp. 1292-1303
    • McHutchison, J.G.1    Manns, M.P.2    Muir, A.J.3
  • 7
    • 38449091418 scopus 로고    scopus 로고
    • Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis
    • Veldt BJ, Heathcote EJ, Wedemeyer H, et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med 2007; 147: 677-84.
    • (2007) Ann Intern Med , vol.147 , pp. 677-684
    • Veldt, B.J.1    Heathcote, E.J.2    Wedemeyer, H.3
  • 8
    • 78649471873 scopus 로고    scopus 로고
    • Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival
    • Tokyo-Chiba Hepatitis Research Group
    • Shiratori Y, Ito Y, Yokosuka O, et al. Tokyo-Chiba Hepatitis Research Group. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival. Ann Intern Med 2005; 18: 142.
    • (2005) Ann Intern Med , vol.18 , pp. 142
    • Shiratori, Y.1    Ito, Y.2    Yokosuka, O.3
  • 9
    • 77954196543 scopus 로고    scopus 로고
    • Antiviral therapy for hepatitis C: Why are so few patients being treated?
    • Volk ML. Antiviral therapy for hepatitis C: why are so few patients being treated? J Antimicrob Chemother 2010; 65: 1327-9.
    • J Antimicrob Chemother , vol.2010 , Issue.65 , pp. 1327-1329
    • Volk, M.L.1
  • 10
    • 42449150116 scopus 로고    scopus 로고
    • Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic
    • McLaren M, Garber G, Cooper C. Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic. Can J Gastroenterol 2008; 22: 133-7.
    • (2008) Can J Gastroenterol , vol.22 , pp. 133-137
    • McLaren, M.1    Garber, G.2    Cooper, C.3
  • 11
    • 22144463864 scopus 로고    scopus 로고
    • Barriers to accessing HIV / AIDS care in North Carolina: Rural and urban differences
    • Reif S, Golin CE, Smith SR. Barriers to accessing HIV / AIDS care in North Carolina: rural and urban differences. AIDS Care 2005; 17: 558-65.
    • (2005) AIDS Care , vol.17 , pp. 558-565
    • Reif, S.1    Golin, C.E.2    Smith, S.R.3
  • 12
    • 0037119025 scopus 로고    scopus 로고
    • Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV / hepatitis C virus coinfected individuals
    • Taylor LE, Costello T, Alt E, Yates G, Tashima K. Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV / hepatitis C virus coinfected individuals. AIDS 2002; 16: 1700-1.
    • (2002) AIDS , vol.16 , pp. 1700-1701
    • Taylor, L.E.1    Costello, T.2    Alt, E.3    Yates, G.4    Tashima, K.5
  • 13
    • 16844370262 scopus 로고    scopus 로고
    • Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: Need for team care
    • Fleming CA, Tumilty S, Murray JE, Nunes D. Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care. Clin Infect Dis 2005; 40(Suppl. 5): S349-54.
    • (2005) Clin Infect Dis , vol.40 , Issue.SUPPL. 5
    • Fleming, C.A.1    Tumilty, S.2    Murray, J.E.3    Nunes, D.4
  • 14
    • 16844384955 scopus 로고    scopus 로고
    • Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users
    • Edlin BR, Kresina TF, Raymond DB, et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005; 40: S276-85.
    • (2005) Clin Infect Dis , vol.40
    • Edlin, B.R.1    Kresina, T.F.2    Raymond, D.B.3
  • 15
    • 0035253612 scopus 로고    scopus 로고
    • Hepatitis C disease among injection drug users: Knowledge, perceived risk, and willingness to receive treatment
    • Stein MD, Maksad J, Clarke J. Hepatitis C disease among injection drug users: knowledge, perceived risk, and willingness to receive treatment. Drug Alcohol Depend 2001; 61: 211-5.
    • (2001) Drug Alcohol Depend , vol.61 , pp. 211-215
    • Stein, M.D.1    Maksad, J.2    Clarke, J.3
  • 16
    • 0031835292 scopus 로고    scopus 로고
    • Barriers to care among persons living with HIV / AIDS in urban and rural areas
    • Heckman TG, Somlai AM, Peters J, et al. Barriers to care among persons living with HIV / AIDS in urban and rural areas. AIDS Care 1998; 10: 365-75.
    • (1998) AIDS Care , vol.10 , pp. 365-375
    • Heckman, T.G.1    Somlai, A.M.2    Peters, J.3
  • 17
    • 23744484452 scopus 로고    scopus 로고
    • Barriers to the treatment of hepatitis C: Patient, provider, and system factors
    • Morrill JA, Shrestha M, Grant RW. Barriers to the treatment of hepatitis C: patient, provider, and system factors. J Gen Intern Med 2005; 20: 754-8.
    • (2005) J Gen Intern Med , vol.20 , pp. 754-758
    • Morrill, J.A.1    Shrestha, M.2    Grant, R.W.3
  • 18
    • 25644435773 scopus 로고    scopus 로고
    • The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone
    • Sylvestre DL, Litwin AH, Clements BJ, Gourevitch MN. The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone. J Subst Abuse Treat 2005; 29: 159-65.
    • (2005) J Subst Abuse Treat , vol.29 , pp. 159-165
    • Sylvestre, D.L.1    Litwin, A.H.2    Clements, B.J.3    Gourevitch, M.N.4
  • 19
    • 37049001443 scopus 로고    scopus 로고
    • Barriers associated with the treatment of hepatitis C virus infection among illicit drug users
    • Grebely J, Genoway KA, Raffa JD, et al. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend 2008; 93: 141-7.
    • (2008) Drug Alcohol Depend , vol.93 , pp. 141-147
    • Grebely, J.1    Genoway, K.A.2    Raffa, J.D.3
  • 20
    • 33748164346 scopus 로고    scopus 로고
    • Social stigmatization and hepatitis C virus infection
    • Zacks S, Beavers K, Theodore D, et al. Social stigmatization and hepatitis C virus infection. J Clin Gastroenterol 2006; 40: 220-4.
    • (2006) J Clin Gastroenterol , vol.40 , pp. 220-224
    • Zacks, S.1    Beavers, K.2    Theodore, D.3
  • 22
    • 42949139729 scopus 로고    scopus 로고
    • Psychiatric symptoms during interferon treatment for hepatitis C: Experiences from a tertiary care hepatology centre
    • Evon DM, Verma A, Simpson K, Galanko JA, Dougherty KA, Fried MW. Psychiatric symptoms during interferon treatment for hepatitis C: experiences from a tertiary care hepatology centre. Aliment Pharmacol Ther 2008; 27: 1071-80.
    • (2008) Aliment Pharmacol Ther , vol.27 , pp. 1071-1080
    • Evon, D.M.1    Verma, A.2    Simpson, K.3    Galanko, J.A.4    Dougherty, K.A.5    Fried, M.W.6
  • 23
    • 33748168698 scopus 로고    scopus 로고
    • Interferoninduced depression in chronic hepatitis C: A review of its prevalence risk factors biology and treatment approaches
    • Asnis GM, De La GR. Interferoninduced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol 2006; 40: 322-35.
    • (2006) J Clin Gastroenterol , vol.40 , pp. 322-335
    • Asnis, G.M.1    De La, G.R.2
  • 26
    • 27644531963 scopus 로고    scopus 로고
    • Depression and anxiety in patients with hepatitis C: Prevalence, detection rates and risk factors
    • Golden J, O'Dwyer AM, Conroy RM. Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry 2005; 27: 431-8.
    • (2005) Gen Hosp Psychiatry , vol.27 , pp. 431-438
    • Golden, J.1    O'Dwyer, A.M.2    Conroy, R.M.3
  • 27
    • 0032936222 scopus 로고    scopus 로고
    • The underrecognition and undertreatment of depression: What is the breadth and depth of the problem?
    • Davidson JR, Meltzer-Brody SE. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? J Clin Psychiatry 1999; 60 (Suppl. 7): 4-9.
    • (1999) J Clin Psychiatry , vol.60 , Issue.SUPPL. 7 , pp. 4-9
    • Davidson, J.R.1    Meltzer-Brody, S.E.2
  • 28
    • 33745940500 scopus 로고    scopus 로고
    • The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes
    • Chao J, Nau DP, Aikens JE, Taylor SD. The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes. Res Social Adm Pharm 2005; 1: 508-25.
    • (2005) Res Social Adm Pharm , vol.1 , pp. 508-525
    • Chao, J.1    Nau, D.P.2    Aikens, J.E.3    Taylor, S.D.4
  • 30
    • 0028272197 scopus 로고
    • A multidimensional model of self-esteem in depression
    • Robert JE, Monroe SM. A multidimensional model of self-esteem in depression. Clin Psychol Rev 1994; 14: 161-81.
    • (1994) Clin Psychol Rev , vol.14 , pp. 161-181
    • Robert, J.E.1    Monroe, S.M.2
  • 32
    • 54049099629 scopus 로고    scopus 로고
    • Introduction: Chronic medical conditions and depression
    • Kravitz RL, Ford DE. Introduction: chronic medical conditions and depression. Am J Med 2008; 121: S1-7.
    • (2008) Am J Med , vol.121
    • Kravitz, R.L.1    Ford, D.E.2
  • 33
    • 84965520932 scopus 로고
    • The CES-D Scale: A selfreport depression scale for research in the general population
    • Radloff LS. The CES-D Scale: a selfreport depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
    • (1977) Appl Psychol Meas , vol.1 , pp. 385-401
    • Radloff, L.S.1
  • 34
    • 0028347548 scopus 로고
    • Screening for depression in well older adults: Evaluation of a short form of the CES-D (Center for Epidemiology Studies Depression Scale)
    • Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiology Studies Depression Scale). Am J Prev Med 1994; 10: 77-84.
    • (1994) Am J Prev Med , vol.10 , pp. 77-84
    • Andresen, E.M.1    Malmgren, J.A.2    Carter, W.B.3    Patrick, D.L.4
  • 35
    • 0036836096 scopus 로고    scopus 로고
    • Screening for depression in a hepatitis C population: The reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D)
    • Clark CH, Mahoney JS, Clark DJ, Eriksen LR. Screening for depression in a hepatitis C population: the reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D). J Adv Nurs 2002; 40: 361-9.
    • (2002) J Adv Nurs , vol.40 , pp. 361-369
    • Clark, C.H.1    Mahoney, J.S.2    Clark, D.J.3    Eriksen, L.R.4
  • 36
    • 1842620533 scopus 로고    scopus 로고
    • Screening for depressive symptoms among HCV-infected injection drug users: Examination of the utility of the CES-D and the Beck Depression Inventory
    • Golub ET, Latka M, Hagan H, et al. Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health 2004; 81: 278-90.
    • (2004) J Urban Health , vol.81 , pp. 278-290
    • Golub, E.T.1    Latka, M.2    Hagan, H.3
  • 38
    • 34848834562 scopus 로고    scopus 로고
    • High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities
    • Evon DM, Verma A, Dougherty KA, et al. High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities. Dig Dis Sci 2007; 52: 3251-8.
    • (2007) Dig Dis Sci , vol.52 , pp. 3251-3258
    • Evon, D.M.1    Verma, A.2    Dougherty, K.A.3
  • 40
    • 0035524961 scopus 로고    scopus 로고
    • Barriers to healthcare access in a non-elderly urban poor American population
    • Ahmed SM, Lemkau JP, Nealeigh N, Mann B. Barriers to healthcare access in a non-elderly urban poor American population. Health Soc Care Community 2001; 9: 445-53.
    • (2001) Health Soc Care Community , vol.9 , pp. 445-453
    • Ahmed, S.M.1    Lemkau, J.P.2    Nealeigh, N.3    Mann, B.4
  • 41
    • 17844398239 scopus 로고    scopus 로고
    • Social cognitive determinants of vaccination behavior against hepatitis B: An assessment among men who have sex with men
    • De Wit JB, Vet R, Schutten M, van Steenbergen J. Social cognitive determinants of vaccination behavior against hepatitis B: an assessment among men who have sex with men. Prev Med 2005; 40: 795-802.
    • (2005) Prev Med , vol.40 , pp. 795-802
    • De Wit, J.B.1    Vet, R.2    Schutten, M.3    Van Steenbergen, J.4
  • 42
    • 33845915386 scopus 로고    scopus 로고
    • AIDS health beliefs and intention for sexual abstinence among male adolescent students in Kathmandu, Nepal: A test of perceived severity and susceptibility
    • Iriyama S, Nakahara S, Jimba M, Ichikawa M, Wakai S. AIDS health beliefs and intention for sexual abstinence among male adolescent students in Kathmandu, Nepal: a test of perceived severity and susceptibility. Public Health 2007; 121: 64-72.
    • (2007) Public Health , vol.121 , pp. 64-72
    • Iriyama, S.1    Nakahara, S.2    Jimba, M.3    Ichikawa, M.4    Wakai, S.5
  • 44
    • 25644443975 scopus 로고    scopus 로고
    • Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection
    • Bini EJ, Brau N, Currie S, et al. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol 2005; 100: 1772-9.
    • (2005) Am J Gastroenterol , vol.100 , pp. 1772-1779
    • Bini, E.J.1    Brau, N.2    Currie, S.3
  • 45
    • 33644757488 scopus 로고    scopus 로고
    • Hepatitis C treatment eligibility and outcomes among patients with psychiatric illness
    • Rifai MA, Moles JK, Short DD. Hepatitis C treatment eligibility and outcomes among patients with psychiatric illness. Psychiatr Serv 2006; 57: 570-2.
    • (2006) Psychiatr Serv , vol.57 , pp. 570-572
    • Rifai, M.A.1    Moles, J.K.2    Short, D.D.3
  • 46
    • 77956643273 scopus 로고    scopus 로고
    • Expanding access to hepatitis C virus treatment-Extension for Community Healthcare Outcomes (ECHO) project: Disruptive innovation in specialty care
    • Arora S, Kalishman S, Thornton K, et al. Expanding access to hepatitis C virus treatment-Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology 2010; 52: 1124-33.
    • Hepatology , vol.2010 , Issue.52 , pp. 1124-1133
    • Arora, S.1    Kalishman, S.2    Thornton, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.